Browse by category

Headline results from Novo Nordisk’s REDEFINE 1 has shown that the trial achieved its primary endpoint by demonstrating a statistically...

The FDA has approved Eli Lilly and Company’s Zepbound (tirzepatide) as the first and only prescription medicine for adults with...

By combining the number of preoperative antihypertensive drugs (ADs) and visceral fat area (VFA) may help predict hypertension (HTN)...

Ascletis Pharma has revealed in a head-to-head diet-induced obese (DIO) mouse study, ASC47 low dose combination 1 (ASC47, 3 mg/kg,...

Asians, non-Hispanic Blacks and Hispanics were significantly less likely than whites to use obesity-management medications (OMMs) to...

About 50% of bariatric patients reported experiencing significantly less or less stress during the holidays compared to the holiday...

Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...

True You Weight Loss, a dedicated endobariatric weight loss center, has announced two new FDA-authorised clinical trials aimed at...

Higher calorie foods were preferred among individuals living with and without obesity despite similar taste and texture, according to a...

Verge Genomics has nominated a second development candidate, VRG201, targeting long-term weight management and metabolic homeostasis....